Atıf Formatları
Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. ÖZDEMİR KUTBAY Et Al. , "Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells," 19th European Congress of Endocrinology , Lisboa, Portugal, 2017

ÖZDEMİR KUTBAY, N. Et Al. 2017. Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells. 19th European Congress of Endocrinology , (Lisboa, Portugal).

ÖZDEMİR KUTBAY, N., Erdogan, M., ŞARER YÜREKLİ, B. P., Çalışkan kurt, c., GÜNDÜZ, C., & BİRAY AVCI, Ç., (2017). Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells . 19th European Congress of Endocrinology, Lisboa, Portugal

ÖZDEMİR KUTBAY, NİLÜFER Et Al. "Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells," 19th European Congress of Endocrinology, Lisboa, Portugal, 2017

ÖZDEMİR KUTBAY, NİLÜFER Et Al. "Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells." 19th European Congress of Endocrinology , Lisboa, Portugal, 2017

ÖZDEMİR KUTBAY, N. Et Al. (2017) . "Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells." 19th European Congress of Endocrinology , Lisboa, Portugal.

@conferencepaper{conferencepaper, author={NİLÜFER ÖZDEMİR Et Al. }, title={Effects of combination of metformin and pioglitazone on AMPK/mTORsignal pathway, p53 and apoptosis in human anaplastic thyroidcancer cells}, congress name={19th European Congress of Endocrinology}, city={Lisboa}, country={Portugal}, year={2017}}